P.S.K Pharma Profile
Key Indicators
- Authorised Capital ₹ 3.00 M
as on 09-12-2024
- Paid Up Capital ₹ 0.87 M
as on 09-12-2024
- Company Age 30 Year, 2 Months
- Last Filing with ROC 31 Mar 2023
- Open Charges ₹ 3.05 Cr
as on 09-12-2024
- Revenue -12.11%
(FY 2023)
- Profit 217.44%
(FY 2023)
- Ebitda 7.90%
(FY 2023)
- Net Worth 7.14%
(FY 2023)
- Total Assets 1.76%
(FY 2023)
About P.S.K Pharma
The Company is engaged in the Healthcare Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2023. It's a company limited by shares with an authorized capital of Rs 3.00 M and a paid-up capital of Rs 0.87 M.
The company currently has active open charges totaling ₹3.05 Cr.
Sadhana Basavraj, Kshitij Basavraj, Sapna Shanbhag, and One other member serve as directors at the Company.
- CIN/LLPIN
U24231KA1994PTC016380
- Company No.
016380
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
11 Oct 1994
- Date of AGM
30 Sep 2023
- Date of Balance Sheet
31 Mar 2023
- Listing Status
Unlisted
- ROC Code
Roc Bangalore
Industry
Company Details
- Location
Davangere, Karnataka, India
- Telephone
- Email Address
- Website
- Social Media-
What products or services does P.S.K Pharma Private Limited offer?
P.S.K Pharma Private Limited offers a wide range of products and services, including Common Disease Medicines, Antiseptic Mouthwashes, Cosmetics, Hair & Beauty Products, Body Lotions, Industrial Chemicals & Supplies, Disinfectant Chemicals, Cleaning Liquids & Wipes, Surface Cleaner, Pharmaceutical Medicine, Skin Care Cosmetics.
Who are the key members and board of directors at P.S.K Pharma?
Board Members(4)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Kshitij Basavraj  | Director | 03-Sep-2003 | Current |
| Sadhana Basavraj | Director | 11-Oct-1994 | Current |
| Sapna Shanbhag | Director | 11-Apr-2016 | Current |
| Basavaraj Harihar | Director | 11-Oct-1994 | Current |
Financial Performance of P.S.K Pharma.
P.S.K Pharma Private Limited, for the financial year ended 2023, experienced significant reduction in revenue, with a 12.11% decrease. The company also saw a substantial improvement in profitability, with a 217.44% increase in profit. The company's net worth moved up by a moderate rise of 7.14%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of P.S.K Pharma?
Unlock access to P.S.K Pharma's control and ownership data, Corporate Shareholding Patterns, Funding (security allotment) details, Foreign Institutional Investor information, Directors and Key Management Personnel (KMP) Remuneration, Group Structure, Overseas Direct Investment and other pertinent data.
Charges (Loans)
| Lender | Amount | Status |
|---|---|---|
Axis Bank Limited Creation Date: 24 Jul 2019 | ₹1.00 M | Open |
Others Creation Date: 23 Mar 2011 | ₹2.40 Cr | Open |
Davangere Harihar Urban Co Op Bank Ltd Creation Date: 23 Apr 1999 | ₹3.50 M | Open |
How Many Employees Work at P.S.K Pharma?
P.S.K Pharma has a workforce of 79 employees as of Apr 08, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Deals i
Gain comprehensive insights into the Deals and Valuation data of P.S.K Pharma, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped P.S.K Pharma's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
_PRIVATE_LIMITED.webp){kind=small}
